Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Research] Samsung Electro-Mechanics (009150) – DS Investment & Securities | Price Hikes Ahead · Shortage Cycle · 2027F Peer Multiple / 2026-05-04 RESEARCH
  • [Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2025-03-21 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Clarification on Rumors or Reports (Unconfirmed) / 2024-03-27 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Trading Suspension and Resumption / 2024-08-22 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Decision on Retirement of Shares / 2025-04-24 Disclosures
  • [Disclosure] SK Square (402340) – Share Cancellation Decision / 2025-03-27 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – (Correction) Decision on Bonus Issue / 2026-07-20 Disclosures
  • [Research] Samsung Electronics (005930) – DS Investment & Securities | DRAM ASP · LTA Visibility · Profit Growth / 2026-07-30 RESEARCH

[Disclosure] Hanwha Aerospace (012450) – Results of Extraordinary General Meeting of Shareholders / 2024-08-14

Posted on August 14, 2024August 10, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hanwha Aerospace approved Agenda Item No. 1, “Approval of Spin-off Plan,” as originally proposed at its Extraordinary General Meeting of Shareholders.

📊 [Key Disclosure Details & Summary of Figures]

  • Company Name: Hanwha Aerospace Co., Ltd.
  • Ticker Symbol: 012450
  • Disclosure Type: Results of Extraordinary General Meeting of Shareholders
  • Disclosure Date: 2024-08-14
  • Resolutions & Voting Outcomes:
    • Agenda Item No. 1: Approval of Spin-off Plan → Approved as Originally Proposed

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Monitoring Spin-off Execution and Subsequent Listing Process

With the approval of the spin-off plan at the extraordinary shareholders’ meeting, the shareholder voting procedure for the corporate spin-off has been completed. Verifying the execution of subsequent milestones—including trading halts, the re-listing of the surviving entity, and the listing of the newly established entity—is essential for evaluating the post-split corporate structure. Progress updates can be verified in upcoming public notices regarding the spin-off, listing disclosures, and Periodic Reports.

📢 Disclaimer and Source Notice

Source: This content was newly structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-08-14
Next Post: [Disclosure] SK Square (402340) – Change of CEO (Representative Executive Officer) / 2024-08-14

Related Posts

  • [Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract / 2024-12-17 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Decision on Disposal of Treasury Stock / 2026-07-13 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Performance (Fair Disclosure) / 2024-04-05 Disclosures
  • [Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in the U.S. / 2024-08-12 Disclosures
  • [Disclosure] Celltrion (068270) – Approval of US FDA Marketing Authorization for Steqeyma (CT-P43, Stelara Biosimilar) / 2024-12-18 Disclosures
  • [Disclosure] ISU PETASYS(007660) – Clarification of Rumors or Reports (Unconfirmed) / 2025-03-24 Semiconductors
  • [Disclosure] Daeduck Electronics (353200) – Investor Relations (IR) Holding (Information Disclosure) / 2024-01-23 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment & Securities | High Bandwidth Recovery · 2024 OP Raised to KRW 18.5T · Target Price Raised / 2024-04-26 RESEARCH
  • [Research] Samsung Electro-Mechanics (009150) – iM Securities | Valuation Reset · MLCC Price Hikes · Server Demand / 2026-07-31 RESEARCH
  • [Disclosure] Samsung Electro-Mechanics (009150) – Decision to Acquire Shares/Equity Securities of Other Corporation / 2026-07-02 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – (Correction) Other Management Matters (Voluntary Disclosure) / 2024-04-16 Semiconductors
  • [Disclosure] Hanwha Systems (272210) – Matters Related to Sustainability Report / 2025-06-25 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Performance / 2024-01-03 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Execution of Material Sales/Supply Contract / 2024-07-02 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme